Survivin antisense compound inhibits proliferation and promotes apoptosis in liver cancer cells

doi:10.3748/wjg.v11.i2.193

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3270)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-1) series.

Item

Count

PDF

320

HTML

2695

Figures (1-6)

140

Tables (1-1)

115

Sum=3270

Jan 14, 2005 (publication date) through May 4, 2024

Times Cited of This Article

Times Cited (21)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Jan 14, 2005; 11(2): 193-199
Published online Jan 14, 2005. doi: 10.3748/wjg.v11.i2.193

Full Size Figure Download Figure

Figure 3 Effect of antisense compound (1:4) on the growth and viability of HepG₂ cells. A: Cells incubated with an increasing concentration of antisense compound (1:4), 600 nmol/L sense compound (1:4), 600 nmol/L LiP, or 600 nmol/L (ODNs) for 48-h after the start of transfection; B: untreated cells; C-E: photomicrographs of HepG₂ cells after a 48-h transfection with (C) 600 nmol/L antisense comound (1:4), (D) 600 nmol/L sense compound (1:4) or (E) 600 nmol/L LiP.

Citation: Dai DJ, Lu CD, Lai RY, Guo JM, Meng H, Chen WS, Gu J. Survivin antisense compound inhibits proliferation and promotes apoptosis in liver cancer cells. World J Gastroenterol 2005; 11(2): 193-199
URL: https://www.wjgnet.com/1007-9327/full/v11/i2/193.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i2.193